Korro Bio, Inc. financial data

Symbol
KRRO on Nasdaq
Location
60 First Street, 2 Nd Floor, Suite 250, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 760 % -32.4%
Return On Equity -68.9 % -37.1%
Return On Assets -45.9 % -19.3%
Operating Margin -1.28K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.42M shares +0.52%
Common Stock, Shares, Outstanding 9.4M shares +0.86%
Entity Public Float 237M USD +1849%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 9.39M shares +0.95%
Weighted Average Number of Shares Outstanding, Diluted 9.39M shares +0.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.37M USD
Research and Development Expense 71.6M USD +15.2%
General and Administrative Expense 30.3M USD -9.95%
Operating Income (Loss) -94.5M USD +1.32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -88.3M USD -0.62%
Income Tax Expense (Benefit) 104K USD +174%
Net Income (Loss) Attributable to Parent -88.4M USD -0.69%
Earnings Per Share, Basic -9 USD/shares -107%
Earnings Per Share, Diluted -9 USD/shares -107%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.2M USD -61.8%
Marketable Securities, Current 68.3M USD -7.41%
Assets, Current 98.2M USD -35.7%
Property, Plant and Equipment, Net 24.4M USD -16.2%
Operating Lease, Right-of-Use Asset 23.3M USD -2.86%
Other Assets, Noncurrent 3.17M USD +50.3%
Assets 162M USD -33.7%
Accounts Payable, Current 2.3M USD -61.3%
Employee-related Liabilities, Current 1.87M USD -43.8%
Accrued Liabilities, Current 5.86M USD +7.36%
Liabilities, Current 14.6M USD +7.55%
Operating Lease, Liability, Noncurrent 41.5M USD -0.63%
Other Liabilities, Noncurrent 1.53M USD +114%
Liabilities 62.5M USD -2.18%
Accumulated Other Comprehensive Income (Loss), Net of Tax 214K USD -62.7%
Retained Earnings (Accumulated Deficit) -334M USD -36%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 99M USD -44.9%
Liabilities and Equity 162M USD -33.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.5M USD -11.7%
Net Cash Provided by (Used in) Financing Activities 172K USD +23.7%
Net Cash Provided by (Used in) Investing Activities 32.8M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 9.4M shares +0.86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.5M USD
Deferred Tax Assets, Valuation Allowance 168M USD +15.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 179M USD +16.4%
Operating Lease, Liability 44.7M USD +6.9%
Depreciation 4.86M USD +14%
Payments to Acquire Property, Plant, and Equipment 119K USD -97.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -88.8M USD -1.54%
Lessee, Operating Lease, Liability, to be Paid 69.8M USD -2.89%
Property, Plant and Equipment, Gross 35.4M USD -9.31%
Operating Lease, Liability, Current 3.15M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.56M USD +2.94%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.34M USD +17.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.1M USD -16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.78M USD +2.92%
Deferred Tax Assets, Operating Loss Carryforwards 94.2M USD +17.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.01M USD
Additional Paid in Capital 433M USD +1.93%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 10.3M USD +33.9%
Share-based Payment Arrangement, Expense 6.94M USD +60.2%
Interest Expense 596K USD -28.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%